LLY

1,076.31

+0.13%↑

JNJ

207.79

+1.08%↑

ABBV

230.14

+0.15%↑

UNH

327.75

+0.78%↑

AZN

92.5

+0.34%↑

LLY

1,076.31

+0.13%↑

JNJ

207.79

+1.08%↑

ABBV

230.14

+0.15%↑

UNH

327.75

+0.78%↑

AZN

92.5

+0.34%↑

LLY

1,076.31

+0.13%↑

JNJ

207.79

+1.08%↑

ABBV

230.14

+0.15%↑

UNH

327.75

+0.78%↑

AZN

92.5

+0.34%↑

LLY

1,076.31

+0.13%↑

JNJ

207.79

+1.08%↑

ABBV

230.14

+0.15%↑

UNH

327.75

+0.78%↑

AZN

92.5

+0.34%↑

LLY

1,076.31

+0.13%↑

JNJ

207.79

+1.08%↑

ABBV

230.14

+0.15%↑

UNH

327.75

+0.78%↑

AZN

92.5

+0.34%↑

Search

ResMed Inc

Închisă

SectorSănătate

244.25 -0.1

Rezumat

Modificarea prețului

24h

Curent

Minim

244.25

Maxim

245.16

Indicatori cheie

By Trading Economics

Venit

-31M

349M

Vânzări

-12M

1.3B

P/E

Medie Sector

25.248

78.892

EPS

2.55

Randament dividend

0.89

Marjă de profit

26.096

Angajați

10,600

EBITDA

-29M

503M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+21.19% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.89%

2.38%

Data viitoare de dividende

19 mar. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-1.8B

36B

Deschiderea anterioară

244.35

Închiderea anterioară

244.25

Sentimentul știrilor

By Acuity

20%

80%

28 / 374 Clasament în Healthcare

ResMed Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

24 dec. 2025, 21:41 UTC

Achiziții, Fuziuni, Preluări

Nvidia to Buy Chip-Designer Groq for $20 Billion, CNBC Reports

24 dec. 2025, 14:57 UTC

Achiziții, Fuziuni, Preluări

Accenture to Acquire Cabel Industry from Fibonacci Group

25 dec. 2025, 23:42 UTC

Market Talk

Nikkei May Trade in Range; Yen in Focus -- Market Talk

25 dec. 2025, 23:40 UTC

Market Talk

Gold Edges Higher Amid Geopolitical Risks -- Market Talk

25 dec. 2025, 00:20 UTC

Achiziții, Fuziuni, Preluări

Nike Climb Boosts Dow, S&P 500 -- 2nd Update

24 dec. 2025, 22:22 UTC

Achiziții, Fuziuni, Preluări

Nvidia, Groq Strike AI Tech Licensing Deal -- Barrons.com

24 dec. 2025, 21:26 UTC

Achiziții, Fuziuni, Preluări

Nvidia to Buy Chip-Designer Groq for $20B, CNBC Reports

24 dec. 2025, 19:35 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

24 dec. 2025, 19:35 UTC

Market Talk

Treasury Yields Decline Ahead of Christmas -- Market Talk

24 dec. 2025, 19:09 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Global Equities Roundup: Market Talk

24 dec. 2025, 19:09 UTC

Market Talk
Achiziții, Fuziuni, Preluări

ServiceNow's Armis Acquisition Shouldn't Fuel Fears That Seat-Based Model Threatened -- Market Talk

24 dec. 2025, 19:06 UTC

Market Talk

Oil Futures Little Changed in Light Pre-Holiday Trade -- Market Talk

24 dec. 2025, 19:03 UTC

Market Talk

U.S. Natural Gas Futures Give Back Some Gains -- Market Talk

24 dec. 2025, 17:20 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Tech, Media & Telecom Roundup: Market Talk

24 dec. 2025, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

24 dec. 2025, 17:08 UTC

Achiziții, Fuziuni, Preluări

This Biotech Stock Soars 39%. Sanofi Is Buying It for $2.2 Billion. -- Barrons.com

24 dec. 2025, 16:53 UTC

Achiziții, Fuziuni, Preluări

Nike Climb Boosts Dow, S&P 500 -- WSJ

24 dec. 2025, 16:31 UTC

Market Talk
Achiziții, Fuziuni, Preluări

ServiceNow Gets Top-Tier Asset and Talent With Armis Buy -- Market Talk

24 dec. 2025, 16:28 UTC

Achiziții, Fuziuni, Preluări

Lam Research Is at All-Time Highs. Its CEO Just Sold $27 Million Worth of Stock. -- Barrons.com

24 dec. 2025, 16:17 UTC

Market Talk

Dollar Stable as U.S. Layoffs Remain at Bay -- Market Talk

24 dec. 2025, 15:33 UTC

Achiziții, Fuziuni, Preluări

Nike Shares Get a Lift After Apple's Tim Cook Doubles His Personal Stake -- WSJ

24 dec. 2025, 15:30 UTC

Achiziții, Fuziuni, Preluări

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

24 dec. 2025, 15:19 UTC

Achiziții, Fuziuni, Preluări

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

24 dec. 2025, 14:49 UTC

Achiziții, Fuziuni, Preluări

Mexico's Ollamani Sells Stake in Azteca Stadium

24 dec. 2025, 14:19 UTC

Market Talk

U.S. Natural Gas Futures Move Lower After Big Jump -- Market Talk

24 dec. 2025, 14:08 UTC

Achiziții, Fuziuni, Preluări

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

24 dec. 2025, 14:06 UTC

Market Talk

Oil Futures Edge Up on Geopolitical Risk Premium -- Market Talk

24 dec. 2025, 13:24 UTC

Market Talk

Canada's Economy Needs More Help Amid Dismal GDP Report -- Market Talk

24 dec. 2025, 12:59 UTC

Achiziții, Fuziuni, Preluări

This Biotech Stock Is Soaring. Sanofi Is Buying It for $2.2 Billion. -- Barrons.com

24 dec. 2025, 12:51 UTC

Achiziții, Fuziuni, Preluări

Disney Could Be the Real Winner from the Warner Takeover Battle. Here's Why. -- Barrons.com

Comparație

Modificare preț

ResMed Inc Așteptări

Obiectiv de preț

By TipRanks

21.19% sus

Prognoză pe 12 luni

Medie 296.44 USD  21.19%

Maxim 345 USD

Minim 260 USD

În baza a 13 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruResMed Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

13 ratings

7

Cumpărare

6

Păstrare

0

Vânzare

Sentiment

By Acuity

28 / 374 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat